Get ready for a new eCorner experience!
Later this summer, eCorner will become part of the website for STVP, the Stanford Engineering Entrepreneurship Center. You'll be able to access all eCorner content at Existing links and bookmarks will redirect. Sign up for our newsletter to stay in the loop!

Going All-In on Infectious Diseases

George Scangos, Vir Biotechnology
In conversation with: Jody Puglisi, Stanford School of Medicine

Vir Biotechnology president and CEO George Scangos explains why many companies struggle to build a sustainable business model around fighting infectious diseases, particularly when it comes to developing antibiotics. However, he adds, certain therapies for viral diseases are currently more financially viable. Dr. Scangos explores why Vir decided to go “all-in” on infectious diseases, how they built a company around that mission, and how the arrival of COVID-19 impacted the young company’s trajectory.